PMGC Holdings (ELAB) Preferred Shares (2022 - 2025)

PMGC Holdings (ELAB) posted Preferred Shares of $637.0 for Q4 2025, little changed sequentially from $637.0 in Q2 2025.

PMGC Holdings (ELAB) Preferred Shares (2022 - 2025) Analysis & Trends

PMGC Holdings has reported Preferred Shares for 3 years, with the latest figure at $637.0 in Q4 2025.

Quarterly Preferred Shares changed N/A year-over-year to $637.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $637.0 (changed N/A YoY) and the FY2025 annual result came in at $637.0, changed N/A from the prior year.
Preferred Shares held at $637.0 in Q4 2025 per ELAB's latest filing, from $637.0 in the prior quarter.
Over five years, Preferred Shares peaked at $21000.0 in Q3 2023 and troughed at $21.0 in Q4 2022.
A 3-year average of $4586.4 and a median of $637.0 in 2025 frame the typical range for Preferred Shares.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	PMGC Holdings	31.22 Mn	12.43 Mn	385,691.00	637.00

Download Data